Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-β1 in synovial fluid aspirates of patients with temporomandibular disorders

Journal of Oral and Maxillofacial Surgery

Volumn 57, Issue 8, 1999, Pages 922-928

  Fang, Ping Ke ^a,b   Ma, Xu Chen ^a,b   Ma, Da Long ^a,c   Fu, Kai Yuan ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Department of Prosthodontics School of Stomatology   (China)

^c Laboratory of Molecular Immunology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; OSTEOARTHRITIS; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 0032809229     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2391(99)90009-5     Document Type: Article

References (38)

1. Westacott CI, Sharif M: Cytokines in osteoarthritis: Mediators or markers of joint destruction? Semin Arthritis Rheum 25:254, 1996
2. Feldmann M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397, 1996
3. Lotz M, Blanco FJ, von Kempis J, et al: Cytokine regulation of chondrocyte functions. J Rheumatol 22:104, 1995 (suppl 43)
4. Pelletier J-P, DiBattista JA, Roughley P, et al: Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 19:545, 1993
5. Leonard AC: Interleukin-1 receptor antagonist. Crit Rev Immunol 15:77, 1995
6. Firestein GS, Boyle DL, Yu C, et al: Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37:644, 1994
7. Moore KW, O'Garra A, de Waal Malefyt R, et al: Interleukin-10. Annu Rev Immunol 11:165, 1993
8. Walmsley M, Katsikis PD, Abney E, et al: Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 39:495, 1996
9. Massagué J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597, 1990
10. Firestein GS, Berger AE, Tracey DE, et al: IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149:1054, 1992
11. Deleuran BW, Chu CQ, Field M, et al: Localization of interleukin-1α, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 31:801, 1992
12. Krzesicki RF, Hatfield CA, Bienkowski MJ, et al: Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts. J Immunol 150:4008, 1992
13. Malyak M, Swaney RE, Arend WP: Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies: Potential contribution from synovial fluid neutrophils. Arthritis Rheum 36:781, 1993
14. Fujikawa Y, Shingu M, Torisu T, et al: Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 54:318, 1995
15. Shingu M, Fujikawa Y, Wada T, et al: Increased IL-1 receptor antagonist (IL-1ra) production and decreased IL-1β/IL-1ra ratio in mononuclear cells from rheumatoid arthritis patients. Br J Rheumatol 34:24, 1995
16. Katsikis PD, Chu CQ, Brennan FM, et al: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179:1517, 1994
17. Cush JJ, Splawski JB, Thomas R, et al: Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 38:96, 1995
18. Fava R, Olsen N, Keski-Oja J, et al: Active and latent forms of transforming growth factor β activity in synovial effusions. J Exp Med 169:291, 1989
19. Brennan FM, Chantry D, Turner M, et al: Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: Lack of effect on spontaneous cytokine production in joint cell cultures. Clin Exp Immunol 81:278, 1990
20. Ma XC, Zhang ZK: Diagnosis and classification of temporomandibular disorders. Chin J Stomatol 33:238, 1998
21. Kubota E, Imamura H, Kubota T, et al: Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 55:20, 1997
22. Fu KY, Ma XC, Zhang ZK, et al: TNF in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 53:424, 1995
23. Rossomando EF, White LB, Hadjimichael J, et al: Immunomagnetic separation of tumor necrosis factor-alpha. I. Batch procedure for human temporomandibular fluid. J Chromatogr 583: 11, 1992
24. Shafer DM, Assael LA, White LB, et al: Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangement. J Oral Maxillofac Surg 52:786, 1994
25. Fu KY, Ma XC, Zhang ZK, et al: Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain 9:i31, 1995
26. Arend WP, Malyak M, Smith MF, et al: Binding of IL-1alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 153:4766, 1994
27. Deleuran BW: Cytokines in rheumatoid arthritis: Localization in arthritic joint tissue and regulation in vitro. Scand J Rheumatol 25:1, 1996 (suppl 104)
28. van Roon JAG, van Roy JLAM, Gmelig-Meyling FHJ, et al: Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 39:829, 1996
29. Weckmann AL, Alcocer-Varela J: Cytokine inhibitors in autoimmune disease. Semin Arthritis Rheum 26:539, 1996
30. Schmid FR, Ogata RI: The composition and examination of synovial fluid. J Prosthet Dent 5:449, 1967
31. Attisano L, Wrana JL, López-Casillas F, et al: TGF-β receptors and actions. Biochim Biophys Acta 1222:71, 1994
32. Attisano L, Wrana JL: Signal transduction by members of transforming growth factor-β superfamily. Cytokine Growth Factor Rev 7:327, 1996
33. Derynck R, Feng XH: TGF-β receptor signaling. Biochim Biophys Acta 1333:F105, 1997
34. Padgett RW, Savage C, Das P: Genetic and biochemical analysis of TGFβ signal transduction. Cytokine Growth Factor Rev 8:1, 1997
35. Heldin C-H, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465, 1997
36. Markowitz SD, Roberts AB: Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 7:93, 1996
37. Venn G, Billingham MEJ, Hardingham TE: Increased proteoglycan synthesis in cartilage in experimental canine osteoarthritis does not reflect a permanent change in chondrocyte phenotype. Arthritis Rheum 38:525, 1995
38. Brandt KD: A pessimistic view of serologic markers for diagnostic and management of osteoarthritis, biochemical, immunologic and clinicopathologic barriers. J Rheumatol 16:39, 1989 (suppl 18)